Vectormune HVT-AIV RSSAuthorisedThis medicine is authorised for use in the European UnionAvian influenza vaccineMedicineVeterinaryAuthorised
Vectormune HVT-AIVOverviewProduct detailsAuthorisation detailsNews on Vectormune HVT-AIVOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Vectormune HVT-AIV Active substance Turkey herpesvirus, strain rHVT/AI-H5 (cell-associated), expressing haemagglutinin gene of Avian influenza subtype H5, Live International non-proprietary name (INN) or common name Avian influenza vaccine Anatomical therapeutic chemical veterinary (ATCvet) code QI01AD Pharmacotherapeutic groupImmunologicals for avesLive viral vaccinesDomestic fowlAuthorisation details EMA product number EMEA/V/C/006288 News on Vectormune HVT-AIVMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-12 February 202514/02/2025This page was last updated on 15/04/2025Share this page